211 related articles for article (PubMed ID: 24516348)
1. NLS-RARα promotes proliferation and inhibits differentiation in HL-60 cells.
Hu XX; Zhong L; Zhang X; Gao YM; Liu BZ
Int J Med Sci; 2014; 11(3):247-54. PubMed ID: 24516348
[TBL] [Abstract][Full Text] [Related]
2. PML(NLS(-)) inhibits cell apoptosis and promotes proliferation in HL-60 cells.
Gao YM; Zhong L; Zhang X; Hu XX; Liu BZ
Int J Med Sci; 2013; 10(5):498-507. PubMed ID: 23532460
[TBL] [Abstract][Full Text] [Related]
3. NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
Xiao C; Zhong L; Shan Z; Xu T; Gan L; Song H; Yang R; Li L; Liu B
Int J Med Sci; 2016; 13(8):611-9. PubMed ID: 27499693
[TBL] [Abstract][Full Text] [Related]
4. [Effect of recombinant adenovirus carrying NLS-RARalpha gene on the proliferation of HL-60 cell and the differentiation of HL-60 cells induced by ATRA and relevant mechanism].
Hu XX; Liu BZ; Zhong L; Gao YM; Zhang X; Wu XJ; Wang H; Zhu XY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):897-901. PubMed ID: 24490497
[TBL] [Abstract][Full Text] [Related]
5. NLS-RARα contributes to differentiation block and increased leukemogenic potential in vivo.
Xiong L; Zhong L; Yu L; Dan W; Ye J; Li J; Liu D; Yuan Z; Yao J; Zhong P; Liu J; Liu B
Cell Signal; 2020 Jan; 65():109431. PubMed ID: 31654721
[TBL] [Abstract][Full Text] [Related]
6. [All-trans retinoic acid promotes differentiation of human leukemia cells by degrading NLS-RARα].
Li J; Liu B; Ye J; Xiong L; Yu L; Zhong P; Yuan Z; Liu D; Yao J; Liu J; Zhong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Dec; 35(12):1082-1087. PubMed ID: 31894006
[TBL] [Abstract][Full Text] [Related]
7. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
8. NLS-RARα blocks cell differentiation by inhibiting the retinoic acid signalling pathway.
Li J; Zhong L; Ye J; Xiong L; Yu L; Dan W; Zhong P; Yuan Z; Liu D; Yao J; Liu J; Liu B
Biochem Biophys Res Commun; 2020 Jul; 528(2):276-284. PubMed ID: 32475642
[TBL] [Abstract][Full Text] [Related]
9. Location of NLS-RARα protein in NB4 cell and nude mice.
Wang H; Yang R; Zhong L; Zhu XY; Ma PP; Yang XQ; Jiang KL; Liu BZ
Oncol Lett; 2017 Apr; 13(4):2045-2052. PubMed ID: 28454360
[TBL] [Abstract][Full Text] [Related]
10. Nuclear import of NLS- RARα is mediated by importin α/β.
Ye J; Zhong L; Xiong L; Li J; Yu L; Dan W; Yuan Z; Yao J; Zhong P; Liu J; Liu D; Liu B
Cell Signal; 2020 May; 69():109567. PubMed ID: 32036017
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cells.
Lane AA; Ley TJ
Mol Cell Biol; 2005 Jan; 25(1):23-33. PubMed ID: 15601827
[TBL] [Abstract][Full Text] [Related]
12. Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/Rarα Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: in Vitro and in Vivo Studies.
Wu D; Shao K; Zhou Q; Sun J; Wang Z; Yan F; Liu T; Wu X; Ye B; Huang H; Zhou Y
Cell Physiol Biochem; 2018; 48(6):2286-2301. PubMed ID: 30114705
[TBL] [Abstract][Full Text] [Related]
13. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells.
Nason-Burchenal K; Allopenna J; Bègue A; Stéhelin D; Dmitrovsky E; Martin P
Blood; 1998 Sep; 92(5):1758-67. PubMed ID: 9716606
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
[TBL] [Abstract][Full Text] [Related]
15. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.
Tabe Y; Konopleva M; Kondo Y; Contractor R; Jin L; Ruvolo V; Tsutsumi-Ishii Y; Miyake K; Miyake N; Ohsaka A; Nagaoka I; Issa JP; Andreeff M
Ann Hematol; 2006 Oct; 85(10):689-704. PubMed ID: 16832676
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha.
Gianni' M; Kalaç Y; Ponzanelli I; Rambaldi A; Terao M; Garattini E
Blood; 2001 May; 97(10):3234-43. PubMed ID: 11342454
[TBL] [Abstract][Full Text] [Related]
17. Activation of
Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
[TBL] [Abstract][Full Text] [Related]
18. NLS-RARα is a novel transcriptional factor.
Jiang KL; Zhong L; Yang XQ; Ma PP; Wang H; Zhu XY; Liu BZ
Oncol Lett; 2017 Dec; 14(6):7091-7098. PubMed ID: 29344139
[TBL] [Abstract][Full Text] [Related]
19. Targeting expression of the leukemogenic PML-RARα fusion protein by lentiviral vector-mediated small interfering RNA results in leukemic cell differentiation and apoptosis.
Ward SV; Sternsdorf T; Woods NB
Hum Gene Ther; 2011 Dec; 22(12):1593-8. PubMed ID: 21846246
[TBL] [Abstract][Full Text] [Related]
20. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
